F S&P 500
5,544.50 +7.50 (+0.14%) F Dow Jones
39,509.00 -17.00 (-0.04%) F Nasdaq
20,028.25 +56.00 (+0.28%) E-mini Russell 2000 Index Futur
2,042.70 -2.20 (-0.11%) Petróleo
81.58 +0.75 (+0.93%) Oro
2,329.80 -1.00 (-0.04%)
Boule Diagnostics AB (publ) (BDABF)
Boule Diagnostics AB (publ)
Domnarvsgatan 4
Spånga 163 53
Sweden
46 87 44 77 00
https://www.boule.com
Sector(es): Healthcare
Industria: Medical Devices
Empleados a tiempo completo: 200
Ejecutivos clave
| Nombre | Título | Pagar | Ejecutado | Año de nacimiento |
|---|---|---|---|---|
| Mr. Torben Nielsen | CEO & Group President | N/D | N/D | N/D |
| Mr. Holger Lembrer M.Sc. | Chief Financial Officer | N/D | N/D | 1984 |
| Mr. Eduardo Pagani | Chief Operating Officer | N/D | N/D | N/D |
| Jorgen Jehander | Head of Development Department & Interim CTO | N/D | N/D | N/D |
| Ms. Simonetta Tumbiolo | Senior Vice President of Marketing | N/D | N/D | N/D |
| Ms. Aishat Bislieva | Senior Vice President of People & Culture | N/D | N/D | N/D |
| Mr. Kiarash Farr | Senior Vice President of Commercial Operations | N/D | N/D | N/D |
| David Metrena | Senior Vice President of Commercial Operations of US | N/D | N/D | N/D |
Descripción
Boule Diagnostics AB (publ) develops, manufactures, and markets instruments and consumable products for blood diagnostics in the United States of America, Asia, Eastern Europe, Latin America, Western Europe, Africa, and the Middle East. The company provides hematology analyzers, reagents, controls, and calibrators, under the Swelab, Medonic, and Quintus brands; and veterinary hematology and clinical chemistry analyzer systems, as well as reagents and panels under the Exigo brand. It serves small and medium-sized hospitals, clinics, laboratories, and veterinary clinics, and other diagnostics companies. Boule Diagnostics AB (publ) was founded in 1956 and is headquartered in Spånga, Sweden.
Gestión corporativa
La calificación ISS Governance QuickScore de Boule Diagnostics AB (publ) a partir del 1 de junio de 2024 es 6. Las puntuaciones principales son Auditoría: 8; Junta: 7; Derechos del accionista: 1; Compensación: 6.
